Related Experiment Videos
Characterization of acidic actin in mouse sarcoma 180 cells
H Ueyama1, K Kurokawa, I Sasaki
1Department of Medical Biochemistry, Shiga University of Medical Science, Ohtsu, Japan.
Cell Structure and Function
|October 1, 1987
Summary
Researchers discovered a novel actin isoform in mouse sarcoma cells. This acidic actin variant, distinct from known forms, suggests new insights into cellular actin diversity and function.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Actin is a highly conserved protein crucial for cell structure and motility.
- Multiple actin isoforms exist, with distinct expression patterns and functions.
- Understanding actin diversity is key to deciphering cellular processes.
Purpose of the Study:
- To identify and characterize a novel actin isoform in mouse sarcoma 180 cells.
- To determine the origin and relationship of this variant actin to known isoforms.
- To investigate the potential implications of this new actin species.
Main Methods:
- Polypeptide analysis using High-Performance Liquid Chromatography (HPLC) and tryptic peptide mapping.
- Affinity chromatography using DNase I-Sepharose.
- Immunological characterization with monoclonal and polyclonal anti-actin antibodies.
- In vitro translation of mRNA to identify the variant actin's genetic origin.
Main Results:
- A polypeptide with actin's molecular weight but increased acidity was identified.
- This polypeptide co-eluted with beta + gamma-actin and reacted with anti-actin antibodies, indicating it's an actin isoform.
- mRNA analysis confirmed it's not a post-translational modification of known actins.
- Differential reactivity with specific antibodies suggested it's related to beta-cytoplasmic actin or a novel species.
Conclusions:
- Mouse sarcoma 180 cells express a unique, acidic actin isoform.
- This variant actin is genetically distinct and not a modified known form.
- Its properties suggest a potential relationship to beta-cytoplasmic actin or represent a novel actin species.